Top Markets
#1 Islamic Coin Islamic Coin +151.53%
#2 Palladium Network Palladium Network +18.73%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#4 clBTC clBTC +12.16%
#5 OpenEden OpenEden +10.74%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.75%
#7 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.73%
#8 MarsCoin MarsCoin +8.66%
#9 Mantle Staked Ether Mantle Staked Ether +8.33%
#10 Mantle Restaked ETH Mantle Restaked ETH +8.01%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NeonMind Biosciences Inc. NeonMind Biosciences Inc.

NeonMind Biosciences Inc.

NMDBF
Clasificación en acciones #40197
NeonMind Biosciences Inc. specializes in the research, formulation, and... NeonMind Biosciences Inc. specializes in the research, formulation, and commercialization of medicinal and psychedelic fungi aimed at treating mental health conditions. The company is actively developing a line of psilocybin-derived products, featuring various mushroom-infused preparations, specifically tailored for weight loss and management. Originally incorporated in 2019 as Flourish Mushroom Labs Inc., it rebranded to NeonMind Biosciences Inc. in April 2020. Headquartered in Oakville, Canada, the company operates as a subsidiary of The Yield Growth Corp.
Precio por acción
$0.228
Última sincronización: 2023-05-23
Capitalización bursátil
$213.62K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio NeonMind Biosciences Inc. (NMDBF)

Categoría

Healthcare
Ratio P/B de NeonMind Biosciences Inc. (NMDBF)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de NeonMind Biosciences Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de NeonMind Biosciences Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE